von Willebrand factor: the old, the new and the unknown von LENTING, P. J., CASARI, C., CHRISTOPHE, O. D., DENIS, C. V.

Volltext

Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis von Susen, S., Rauch, A., Van Belle, E., Vincentelli, A., Lenting, P.J.

Volltext

Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome von HULSTEIN, J. J. J., VAN RUNNARD HEIMEL, P. J., FRANX, A., LENTING, P. J., BRUINSE, H. W., SILENCE, K., DE GROOT, PH. G., FIJNHEER, R.

Volltext

von Willebrand factor and inflammation von Kawecki, C., Lenting, P. J., Denis, C. V.

Volltext

Increased metastatic potential of tumor cells in von Willebrand factor‐deficient mice von TERRAUBE, V., PENDU, R., BARUCH, D., GEBBINK, M. F. B. G., MEYER, D., LENTING, P. J., DENIS, C. V.

Volltext

Clearance of von Willebrand factor von Casari, C., Lenting, P. J., Wohner, N., Christophe, O. D., Denis, C. V.

Volltext

Shear stress‐independent binding of von Willebrand factor‐type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance von Wohner, N., Legendre, P., Casari, C., Christophe, O. D., Lenting, P. J., Denis, C. V.

Volltext

Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII von LENTING, P. J, DONATH, M.-J. S. H, VAN MOURIK, J. A, MERTENS, K

Volltext

Clearance mechanisms of von Willebrand factor and factor VIII von LENTING, P. J., VAN SCHOOTEN, C. J. M., DENIS, C. V.

Volltext

LDL receptor‐related protein 1 contributes to the clearance of the activated factor VII–antithrombin complex von Fazavana, J. G., Muczynski, V., Proulle, V., Wohner, N., Christophe, O. D., Lenting, P. J., Denis, C. V.

Volltext

Characterization of the interaction between von Willebrand factor and osteoprotegerin von SHAHBAZI, S., LENTING, P. J., FRIBOURG, C., TERRAUBE, V., DENIS, C. V., CHRISTOPHE, O. D.

Volltext

P5812Acquired von willebrand factor defect under continuous-flow ventricular assist devices: modulation by dynamic changes of pulsatility von Vincent, F., Rauch, A., Loobuyck, V., Spillemaeker, H., Nix, C., Vincentelli, A., Moussa, M., Lemesle, G., Paris, C., Dupont, A., Richardson, M., Staels, B., Lenting, P.J., Van Belle, E., Susen, S.

Volltext

OC 56.5 In vitro and in vivo Amelioration of the von Willebrand Disease Type 2B Phenotype Using an Allele-specific siRNA von De Jong, A, Casari, C, Dirven, R.J., Van Vlijmen, B.J.M., Lenting, P.J., Denis, C.V., Eikenboom, J.

Volltext

Cysteine‐mutations in von Willebrand factor associated with increased clearance von SCHOOTEN, C. J., TJERNBERG, P., WESTEIN, E., TERRAUBE, V., CASTAMAN, G., MOURIK, J. A., HOLLESTELLE, M. J., VOS, H. L., BERTINA, R. M., BERG, H. M., EIKENBOOM, J. C. J., LENTING, P. J., DENIS, C. V.

Volltext

ADAMTS‐13: double trouble for von Willebrand factor von LENTING, P. J., RASTEGARLARI, G.

Volltext

von Willebrand factor clearance does not involve proteolysis by ADAMTS‐13 von BADIROU, I., KURDI, M., RAYES, J., LEGENDRE, P., CHRISTOPHE, O. D., LENTING, P. J., DENIS, C. V.

Volltext

Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients von HOLLESTELLE, M. J., LOOTS, C. M., SQUIZZATO, A., RENNÉ, T., BOUMA, B. J., DE GROOT, P. G., LENTING, P. J., MEIJERS, J. C. M., GERDES, V. E. A.

Volltext

The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission von GROOT, E., FIJNHEER, R., SEBASTIAN, S. A. E., DE GROOT, PH. G., LENTING, P. J.

Volltext

Towards standardization of in vivo thrombosis studies in mice von DENIS, C. V., DUBOIS, C., BRASS, L. F., HEEMSKERK, J. W. M., LENTING, P. J.

Volltext

The effect of exercise on von Willebrand factor and ADAMTS‐13 in individuals with type 1 and type 2B von Willebrand disease von STAKIW, J., BOWMAN, M., HEGADORN, C., PRUSS, C., NOTLEY, C., GROOT, E., LENTING, P. J., RAPSON, D., LILLICRAP, D., JAMES, P.

Volltext